about
The acquisition and application of absorption, distribution, metabolism, and excretion (ADME) data in agricultural chemical safety assessments.Lack of pharmacokinetic interaction between tiagabine and erythromycin.Lopinavir/Ritonavir pharmacokinetic profile: impact of sex and other covariates following a change from twice-daily to once-daily therapy.Sex-dependent modulation of treatment responseIntrinsic sexually dimorphic expression of the principal human CYP3A4 correlated with suboptimal activation of GH/glucocorticoid-dependent transcriptional pathways in men.Effect of age and gender on the pharmacokinetics of eprosartan.Effects of sex on the pharmacokinetic and pharmacodynamic properties of quinidine.Differences between clinical trials and postmarketing use.Sex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men.Gender: a possible determinant in dosing of dermatologic drugs--an overview.Strategies to assess the drug interaction potential in translational medicine.Inherent sex-dependent regulation of human hepatic CYP3A5Sex differences in the toxicity of polyethylene glycol-coated gold nanoparticles in mice.Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs.The effect of piperine on midazolam plasma concentration in healthy volunteers, a research on the CYP3A-involving metabolism.Sex differences in pharmacokinetics of antidepressants.Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex.Chronic Organic Solvent Exposure Changes Visual Tracking in Men and Women.Toxicokinetics of organic solvents: a review of modifying factors.Gender-Related Differences in the Expression of Organic Cation Transporter 2 and its Role in Urinary Excretion of Metformin in Rats.Women encounter ADRs more often than do men.Sex-dependent genetic markers of CYP3A4 expression and activity in human liver microsomes.Acetaminophen metabolism does not contribute to gender difference in its hepatotoxicity in mouse.
P2860
Q31041215-7A172F17-5F68-4EAB-A878-87725B786F8BQ33488034-A4D27E90-7B7F-4A32-8410-C729B98E6F04Q34776414-142AC029-A0B2-4010-A148-E30F5884C7F3Q35236761-E45D59B0-9B05-458D-B739-D9AC6A1C276FQ35590828-C313077B-06A5-460E-86FA-E087828D13A9Q35802593-8717E311-D2BD-4610-95E8-867D38E7C554Q35825448-69B230B9-6932-4946-8E3C-1A236E9B2CADQ35825899-1A2CC693-9C8E-4C4F-94AD-DFC9B9FF7B51Q35885251-E7F81BCE-FD8C-4BA5-B984-F9E037562709Q36596188-EE19DD24-182F-4432-917C-A68839242E29Q36609743-F5105012-3BC6-4C56-8121-2CA04F44C664Q36781075-222367E7-C635-4FB1-B12E-3A5D25CE6541Q37000155-6FAE2CCC-9E3A-4F5F-8957-C935A271AA55Q37256195-8BAE26E9-7EE8-486D-BB9F-A44F293FB7FDQ37523782-3DE01C9B-C8B9-4B76-8961-169A4F805552Q37824711-9B03FF24-2DFB-48FB-9CD3-A05671519731Q38078561-B20740DB-DF29-4905-93D5-81DB3B8548DDQ47109111-F6412F52-AE9E-481A-ACFB-B26CB88016AFQ50851509-E98689F5-BD24-43F1-9BC0-B6BA75558B85Q51033836-CA5B968A-C5F4-4C8D-89A4-1A99093C648EQ51695259-81A64E3C-F4B2-426B-9D7D-37BD6379ADA2Q51755245-12741A9B-D2F2-44EA-A7F8-A6D0BD153C55Q51810808-E760AB32-62DA-4EC9-B9C6-2BA9C8B34DC5
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Gender differences in pharmacokinetics.
@en
type
label
Gender differences in pharmacokinetics.
@en
prefLabel
Gender differences in pharmacokinetics.
@en
P2860
P356
P1476
Gender differences in pharmacokinetics.
@en
P2093
C H Gleiter
U Gundert-Remy
P2860
P2888
P304
P356
10.1007/BF03190260
P577
1996-04-01T00:00:00Z
P6179
1006840073